Filing metadata

Accession number
0001209191-21-046010
Form type
Form 3
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Jul 08, 2021
Reporting period
Jul 06, 2021
Description
Initial ownership

Explore SEC Filings Hub